Latest News On Oklahoma

Latest KFF Health News Stories

Pain Meds As Public Nuisance? Oklahoma Tests A Legal Strategy Against Opioid Maker

KFF Health News Original

Oklahoma is seeking $17 billion in damages from Johnson & Johnson, the pharmaceutical giant. After a seven-week trial, a judge will decide if the opioid drugmaker is liable and if so, for how much.

Oklahoma’s ‘Precedent-Setting’ Suit Puts Opioid Drugmakers On Trial

KFF Health News Original

As states struggle to respond to the national drug crisis, officials around the country are watching Oklahoma. The state’s attorney general says opioid drugmakers helped ignite a health crisis that has killed thousands of residents.

Plan de Trump para combatir el VIH puede encontrar barreras en la América rural

KFF Health News Original

En algunos estados no se habla de sexo ni de VIH. Oklahoma, por ejemplo, tiene la tasa más alta de pruebas tardías de VIH: las personas se hacen el test cuando ya desarrollaron SIDA.

Trump Plan To Beat HIV Hits Rough Road In Rural America

KFF Health News Original

Health officials and doctors treating patients with HIV welcome the funding push, but warn that the strategies that work in progressive cities don’t necessarily translate to rural areas.

As States Try To Rein In Drug Spending, Feds Slap Down One Bold Medicaid Move

KFF Health News Original

Medicaid drug spending doubled in five years in Massachusetts. The state wanted to exclude expensive drugs that weren’t proven to work better than existing alternatives from its Medicaid plan, but the federal government blocked the effort.

HHS, States Move To Help Insurers Defray Costs Of Sickest Patients

KFF Health News Original

In a letter to all governors, HHS Secretary Tom Price invited them to consider seeking federal help to set up reinsurance funds that would help cover losses that insurers have because of high numbers of sick patients.

UnitedHealthcare To Exit All But ‘Handful’ Of Obamacare Markets In 2017

KFF Health News Original

UnitedHealthcare said Tuesday it will leave most of the 34 states in which it offers health insurance under Obamacare, but Nevada and Virginia are two markets it will retain a presence.